Working… Menu
Trial record 23 of 80 for:    "Adult Acute Lymphocytic Leukemia" | "Antineoplastic Agents, Hormonal"

Chemotherapy With Liposomal Cytarabine CNS Prophylaxis for Adult Acute Lymphoblastic Leukemia & Lymphoblastic Lymphoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02043587
Recruitment Status : Active, not recruiting
First Posted : January 23, 2014
Last Update Posted : October 19, 2018
Leadiant Biosciences, Inc.
Information provided by (Responsible Party):
Matthew Wieduwilt, M.D., Ph.D., University of California, San Diego

No Study Results Posted on for this Study
Recruitment Status : Active, not recruiting
Estimated Primary Completion Date : January 2020
Estimated Study Completion Date : January 2020